Help us expand our work.

Your gift will help us advocate for psoriasis and psoriatic arthritis to remain a focus of federally funded biomedical research; will help us combat media that trivializes psoriatic disease; and will help us educate people with psoriasis, and their families, to be savvy and knowledgeable consumers as they seek out the psoriasis treatments that will help them live their best lives.

Please donate today.

The Latest Psoriasis News

Company behind Humira and Skyrizi asks regulators to green-light Rinvoq for psoriatic arthritis
Company behind Humira and Skyrizi asks regulators to green-light Rinvoq for psoriatic arthritis

AbbVie, the North Chicago company behind the longtime blockbuster biologic Humira (adalimumab) and the new biologic Skyrizi (risankizumab-rzaa), has asked the U.S. Food and Drug Administration (FDA) and its European counterpart to approve its rheumatoid arthritis (RA) drug Rinvoq (upadacitinib) for psoriatic arthritis. Rinvoq is a JAK inhibitor administered as Continue Reading…

Our new “Psoriasis Journey” campaign is rolling out
Our new “Psoriasis Journey” campaign is rolling out

Our new Psoriasis Journey campaign is rolling out now to prep for for an official June 8, 2020 launch. On that date, our volunteer patient with severe psoriasis is going to begin one of the cutting-edge psoriasis treatments we’ve been hearing so much about. You can follow along with his Continue Reading…

Want to try an experimental psoriasis treatment for your skin or scalp?
Want to try an experimental psoriasis treatment for your skin or scalp?

Before a doctor can prescribe a treatment, it goes through years of research and testing, including multiple rounds of clinical trials, using volunteer patients to test a potential treatment’s safety and effectiveness. The clinical trials are developed in consultation with government regulators (here, the US Food and Drug Administration, or Continue Reading…